According to Merck KGaA's latest financial reports the company's current EPS (TTM) is $7.46. In 2022 the company made an earnings per share (EPS) of $8.03 a decrease over its 2021 EPS that were of $8.18.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $7.46 | -7.19% |
2022 | $8.03 | -1.74% |
2021 | $8.18 | 53.88% |
2020 | $5.31 | 56.65% |
2019 | $3.39 | -62.19% |
2018 | $8.97 | 29.13% |
2017 | $6.95 | 66.49% |
2016 | $4.17 | 46.27% |
2015 | $2.85 | -18.21% |
2014 | $3.49 | -5.25% |
2013 | $3.68 | 114.63% |
2012 | $1.72 | -10.04% |
2011 | $1.91 | -0.45% |
2010 | $1.92 | 60.54% |
2009 | $1.19 |